Influenza A virus lacking M2 protein as a live attenuated vaccine.
about
Relevance of Viroporin Ion Channel Activity on Viral Replication and PathogenesisHost defense mechanism-based rational design of live vaccineSeveral hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984.High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses.M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice.Cross-protective immunity to influenza A viruses.An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virusNew strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.A (H1N1) pdm09 HA D222 variants associated with severity and mortality in patients during a second wave in MexicoDNAVaxDB: the first web-based DNA vaccine database and its data analysis.Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesisDevelopment of an Alternative Modified Live Influenza B Virus Vaccine.Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets.Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus.Inflammasomes as mediators of immunity against influenza virus.Role of the CM2 protein in the influenza C virus replication cycleViral miniproteinsReplication-incompetent influenza A viruses that stably express a foreign genePerforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasomeInfluenza A surface glycosylation and vaccine design.Viroporins, Examples of the Two-Stage Membrane Protein Folding Model.Bluetongue virus nonstructural protein NS3/NS3a is not essential for virus replication.Principles underlying rational design of live attenuated influenza vaccines.Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity
P2860
Q26823195-F3C86BBB-701C-48B6-8E3D-384B1D519774Q30354189-D14AD86E-3E3F-4438-BD5B-AE52B3666B0CQ30385956-54BB2D65-4B76-4C0C-BF01-DCAEBF72A19AQ30392309-E31AC29F-7A12-4484-A5CF-A77DA1D8B0A6Q30392561-292E2249-D63D-4FA6-9B84-F6F2E2AD9B90Q30396399-46C6FE5E-04CD-43E1-995F-6329EF332F89Q30399023-F2CC6759-2F1C-48D3-A770-D2DD8EE791E7Q30407424-6B3FD21D-514D-457D-8CBA-E4CAE5107130Q30426641-DE8C34FA-2EE1-48EF-BC9B-EC19265B6D11Q30841376-33CDF844-3C4F-492E-A92A-24A9CEBE5CE0Q33553636-C50693E0-B2A0-429C-A31C-3E118FD6CFE6Q33733453-EC982BC7-8CDA-4064-92FD-B0F6A3DE965EQ33826890-2534B53E-556F-405A-99E3-D8B212404C6DQ34261441-DA8EFEFD-7DF7-45A8-BDE0-8D370947552EQ34474244-CD88978B-0C7B-4E11-81AF-838305D76C3EQ34487807-C1B8568E-B302-4C1B-B944-5176FB9ADD4EQ35151120-EBAB18A7-D4A2-4908-B692-AA58DDAB60D9Q35961330-696341F2-6150-477A-ACA4-EC6F97E3DCE8Q36018212-686D9EC1-87F7-4065-A646-D153C1A729B9Q36202621-4097D340-BED9-49D2-89EF-9D4B05CE35D9Q37589948-F7239C27-0DC2-42DA-9888-643393F7E0E0Q38541409-B33A1916-32E6-4830-8A9C-2A2BEFAE4939Q39030331-2B179688-7393-4D8B-92DC-48A0A981EDE8Q39770895-AB9A9FE6-019E-4121-837D-16CCFCB40A10Q57093953-23D5F29F-939C-4A92-ACB5-BF3F0358172C
P2860
Influenza A virus lacking M2 protein as a live attenuated vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influenza A virus lacking M2 protein as a live attenuated vaccine.
@en
Influenza A virus lacking M2 protein as a live attenuated vaccine.
@nl
type
label
Influenza A virus lacking M2 protein as a live attenuated vaccine.
@en
Influenza A virus lacking M2 protein as a live attenuated vaccine.
@nl
prefLabel
Influenza A virus lacking M2 protein as a live attenuated vaccine.
@en
Influenza A virus lacking M2 protein as a live attenuated vaccine.
@nl
P2860
P356
P1433
P1476
Influenza A virus lacking M2 protein as a live attenuated vaccine.
@en
P2093
Shinji Watanabe
Tokiko Watanabe
P2860
P304
P356
10.1128/JVI.00450-09
P407
P577
2009-03-25T00:00:00Z